Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00067730
Status:
COMPLETED
Last Update Posted:
2007-12-07
First Post:
2003-08-25
Brief Title:
A Safety Evaluation of Drotrecogin Alfa Activated in Patients With Blood Cancer Severe Infection Related to Bone Marrow Transplantation
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Sepsis |
| Hematologic Neoplasms |
| Hematopoietic Stem Cell Transplantation |
| Infection |
Keywords: